Related Experiment Video
Updated: Sep 6, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
The crossroads of adenosinergic pathway and epithelial-mesenchymal plasticity in cancer
Isabele Cristiana Iser1, Samlai Vedovatto2, Fernanda Dittrich Oliveira2
1Department of Basics Health Sciences and Laboratory of Cell Biology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
Abstract:
Epithelial-mesenchymal transition (EMT) is a key mechanism related to tumor progression, invasion, metastasis, resistance to therapy and poor prognosis in several types of cancer. However, targeting EMT or partial-EMT, as well as the molecules involved in this process, has remained a challenge. Recently, the CD73 enzyme, which hydrolyzes AMP to produce adenosine (ADO), has been linked to the EMT process. This relationship is not only due to the production of the immunosuppressant ADO but also to its role as a receptor for extracellular matrix proteins, being involved in cell adhesion and migration. This article reviews the crosstalk between the adenosinergic pathway and the EMT program and the impact of this interrelation on cancer development and progression. An in silico analysis of RNAseq datasets showed that several tumor types have a significant correlation between an EMT score and NT5E (CD73) and ENTPD1 (CD39) expressions, with the strongest correlations being in prostate adenocarcinoma. Furthermore, it is evident that the cooperation between EMT and the adenosinergic pathway in tumor progression is context and tumor-dependent. The increased knowledge about this topic will help broaden the view to explore new treatments and therapies for different types of cancer.
Insights
Epithelial-mesenchymal transition (EMT) links to cancer progression. The adenosinergic pathway, involving CD73, influences EMT, offering potential new therapeutic targets for various cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Epithelial-mesenchymal transition (EMT) is crucial in tumor progression, invasion, metastasis, therapy resistance, and poor prognosis.
- Targeting EMT and its associated molecules presents a significant challenge in cancer treatment.
- The CD73 enzyme's role in adenosine production and extracellular matrix interaction links it to EMT.
Purpose of the Study:
- To review the crosstalk between the adenosinergic pathway and the EMT program.
- To explore the impact of this interrelation on cancer development and progression.
- To identify potential therapeutic strategies based on this relationship.
Main Methods:
- In silico analysis of RNAseq datasets.
- Correlation analysis between EMT scores and gene expression (NT5E/CD73, ENTPD1/CD39).
- Literature review of the adenosinergic pathway and EMT.
Main Results:
- Significant correlations found between EMT scores and CD73/CD39 expression in various tumor types.
- Prostate adenocarcinoma showed the strongest correlations.
- The interplay between EMT and the adenosinergic pathway is tumor- and context-dependent.
Conclusions:
- The adenosinergic pathway, particularly CD73, is closely intertwined with EMT in cancer.
- Understanding this crosstalk provides new avenues for cancer therapy development.
- Further research into this relationship can lead to novel treatment strategies for diverse cancers.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cancer Cell Migration through Invadopodia
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment

